The short version

From the latest prices and each company's SEC filings. Who's ahead on each measure, not which to buy.

  • Molina Healthcare is the larger company, worth $9.9B, about 4.0 times Clover Health Investments.
  • Clover Health Investments grew revenue faster over the last year (+55.6% vs -4.8%).
  • Molina Healthcare keeps more of each dollar of revenue as operating profit (0.5% vs -0.7%).

Side by side

The stronger figure is shaded where higher (or, for valuation multiples, lower) reads as better. How the implied growth works.

MeasureCLOVMOH
Market cap$2.5B$9.9B
Share price$4.79$196.93
Revenue (last fiscal year)$1.9B$45.4B
Free cash flow (last fiscal year)-$69M-$636M
Revenue growth, last year+55.6%-4.8%
Revenue growth per year, last 5 fiscal years+6.9%+13.1%
Operating margin-0.74%0.46%
Net margin-0.74%-0.02%
Return on equity-4.9%-0.17%
P/E (trailing)—50.8x
Price / free cash flow——
EV / EBITDA—12.5x
FCF growth the price implies——
Dividend yield——
Debt / equity0.91x2.84x
Fundamental gradeDF
Superinvestors holding it17
Insider purchases, last 12 months04

Results from SEC filings

Revenue and free cash flow by fiscal year, from each company's 10-K filings.

Clover Health Investments

YearRevenueFree cash flowOp. margin
2021$1.5B-$283M-43.3%
2022$1.1B-$208M-26.1%
2023$1.3B-$145M-16.3%
2024$1.4B$33M-3.3%
2025$1.9B-$69M-4.4%

Molina Healthcare

YearRevenueFree cash flowOp. margin
2021$27.8B$2.0B3.7%
2022$32.0B$682M3.7%
2023$34.1B$1.6B4.6%
2024$40.6B$544M4.2%
2025$45.4B-$636M1.7%

Where the revenue comes from

Clover Health Investments

No segment breakdown reported.

Molina Healthcare · by segments, 2023

Medicaid$27.7B81%
Medicare$4.2B12%
Marketplace$2.1B6%
Other$76M0%
Compare them in fullFifteen years of statements, quarterly results, DCF and IRR models, and any number of peers side by side.
Open CLOV in Investingly

Questions

Which is bigger, Clover Health Investments or Molina Healthcare?

Molina Healthcare (MOH), at $9.9B against $2.5B.

Which grows faster, CLOV or MOH?

Clover Health Investments: revenue grew +55.6% over the last year, against -4.8%.

Prices and ratios as of the last daily update; statements from SEC filings. Information only, not investment advice.